Home/Filings/4/0001181431-04-058222
4//SEC Filing

SYNBIOTICS CORP 4

Accession 0001181431-04-058222

CIK 0000719483operating

Filed

Dec 12, 7:00 PM ET

Accepted

Dec 13, 11:09 AM ET

Size

16.2 KB

Accession

0001181431-04-058222

Insider Transaction Report

Form 4
Period: 2004-12-10
DONELAN THOMAS A
Director10% Owner
Transactions
  • Other

    Common Stock

    2004-12-10$0.18/sh+22,622$3,981735,488 total(indirect: By LLC)
  • Other

    Common Stock

    2004-12-10$0.18/sh+49,989$8,798382,202 total
Holdings
  • Series C Preferred Stock

    (indirect: By LLC)
    Common Stock (21,796,668 underlying)
    21,796,668
  • Series C Preferred Stock

    (indirect: By LLC)
    Common Stock (778,452 underlying)
    778,452
  • Common Stock Warrant

    (indirect: By LLC)
    Exercise: $0.17From: 2004-09-23Exp: 2010-09-01Common Stock (250,000 underlying)
    250,000
Footnotes (6)
  • [F1]Acquired pursuant to the election of Redwood West Coast, LLC in lieu of cash dividends on Synbiotics Corporation's Series C Preferred Stock held by Redwood West Coast, LLC, as permitted by the Certificate of Determination of the Series C Preferred Stock of Synbiotics Corporation. As required by its Operating Agreement, Redwood West Coast, LLC directed that the shares of Common Stock be issued directly to its members. Mr. Donelan received 49,989 shares of Common Stock of Synbiotics Corporation in this distribution.
  • [F2]Acquired pursuant to the election of Redwood West Coast, LLC in lieu of cash dividends on Synbiotics Corporation's Series C Preferred Stock held by Redwood West Coast, LLC, as permitted by the Certificate of Determination of the Series C Preferred Stock of Synbiotics Corporation. As required by its Operating Agreement, Redwood West Coast, LLC directed that the shares of Common Stock be issued directly to its members. Redwood Holdings, LLC received 11,969 shares of Common Stock of Synbiotics Corporation in this distribution. Redwood Holdings, LLC is the owner of record of 735,488 shares of Common Stock of Synbiotics Corporation. Mr. Donelan is a 24.9% owner of Redwood Holdings, LLC, which has sole voting and dispositive power with respect to the shares. Mr. Donelan disclaims beneficial ownership of the shares reflected above, except to the extent of his direct pecuniary interest in Redwood Holdings, LLC.
  • [F3]Acquired in lieu of cash dividends on Synbiotics Corporation's Series C Preferred Stock held by Redwood Holdings, LLC, as permitted by the Certificate of Determination of the Series C Preferred Stock of Synbiotics Corporation. Redwood Holdings, LLC received 10,653 shares of Common Stock of Synbiotics Corporation in this distribution. Redwood Holdings, LLC is the owner of record of 735,488 shares of Common Stock of Synbiotics Corporation. Mr. Donelan is a 24.9% owner of Redwood Holdings, LLC, which has sole voting and dispositive power with respect to the shares. Mr. Donelan disclaims beneficial ownership of the shares reflected above, except to the extent of his direct pecuniary interest in Redwood Holdings, LLC.
  • [F4]See Exhibit 99.1 to this Form 4.
  • [F5]On September 23, 2004, Redwood Holdings, LLC purchased 100 shares of Series C Convertible Preferred Stock of Synbiotics Corporation. Redwood Holdings, LLC is the beneficial owner of 100 shares of Series C Convertible Preferred Stock of Synbiotics Corporation. Mr. Donelan is a 24.9% owner of Redwood Holdings, LLC. In addition, Mr. Donelan serves on the Management Committee of Redwood Holdings, LLC, which has sole voting and dispositive power with respect to the shares. The shares are convertible into shares of common stock at any time into such number of shares of common stock by dividing each share of Series C Convertible Preferred Stock, valued at $1,000, by the conversion price - initially set at $0.12846. Mr. Donelan disclaims beneficial ownership of the shares reflected above, except to the extent of his direct pecuniary interest in Redwood Holdings, LLC.
  • [F6]On September 23, 2004, in conjunction with a credit agreement, Remington Capital, LLC received a warrant to purchase 250,000 shares of Common Stock of Synbiotics Corporation with an exercise price of $0.17 per share. The warrant is exercisable at any time, in whole or in part, through September 1, 2010. Remington Capital, LLC is indirectly owned 100% by Redwood Holdings, LLC. Mr. Donelan is a 24.9% owner of Redwood Holdings, LLC. Mr. Donelan disclaims beneficial ownership of the shares reflected above, except to the extent of his direct pecuniary interest in Redwood Holdings, LLC.

Issuer

SYNBIOTICS CORP

CIK 0000719483

Entity typeoperating
IncorporatedCA

Related Parties

1
  • filerCIK 0000719483

Filing Metadata

Form type
4
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 11:09 AM ET
Size
16.2 KB